TL;DR We have tier licensing for Atlassian products at 200-300 users. Our Atlassian Guard user count is exceeding this because of the size of our identity provider sync group members. The total licensed users for each product (besides JSM) should be nearly identical (~280 licensed users).
We are using Entra ID to provision users into Atlassian through synced groups, and I am trying to confirm how Confluence guest users affect Atlassian Guard licensing.
My understanding is:
Can someone confirm whether this understanding is correct?
More specifically:
I want to make sure we are separating product licensing, identity-provider provisioning, and Guard billing correctly.
Hi @Brent Lee
Guests do not count towards individual apps' licenses but they do count towards the user count.
As you may recall, you can add up to 5 guests per a paid licensed user but the total amount of users cannot exceed the maximum permissible user count (Confluence = 250K users).
It seems that if you choose to provision them via your identity provider, they will count. But apparently, you can opt them out.
As to whether you need to provision guests via your SAML SSO, this article may help: https://support.atlassian.com/security-and-access-policies/docs/what-is-external-user-security/
There's a similar Community question here: https://community.atlassian.com/forums/Confluence-questions/how-does-Guard-count-the-guest/qaq-p/3063757
I would suggest that you contact Atlassian billing Support to discuss your specific setup - https://www.atlassian.com/company/contact/purchasing-licensing#/
Other than that, there are solutions allow you to let external users, who are within your identity provider, access your Confluence content outside the Atlassian ecosystem (outside Guard and Confluence licensing). In other words, you can enable controlled access to Confluence content to users who are not users or guests, without enabling anonymous access.
You must be a registered user to add a comment. If you've already registered, sign in. Otherwise, register and sign in.